Register

SmallMolecules.com > Supplier: caymanchemical

Cayman Chemical

Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Company Website

Product Listing

ZK 118182 isopropyl ester 100 µg | ≥98%

Cayman Chemical

The prodrug form of a potent DP receptor agonist

More Information Supplier Page

ZK 159222 500 µg | ≥95%

Cayman Chemical

An antagonist of the vitamin D receptor

More Information Supplier Page

ZK 756326 (hydrochloride) 25 mg | ≥98%

Cayman Chemical

A non-peptide agonist of CCR8

More Information Supplier Page

ZK 756326 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

A non-peptide agonist of CCR8

More Information Supplier Page

ZK 756326 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

A non-peptide agonist of CCR8

More Information Supplier Page

ZK 824859 10 mg | ≥98%

Cayman Chemical

An inhibitor of uPA

More Information Supplier Page

ZK 824859 25 mg | ≥98%

Cayman Chemical

An inhibitor of uPA

More Information Supplier Page

ZK 824859 5 mg | ≥98%

Cayman Chemical

An inhibitor of uPA

More Information Supplier Page

ZK 824859 50 mg | ≥98%

Cayman Chemical

An inhibitor of uPA

More Information Supplier Page

ZL006 50 mg | ≥98%

Cayman Chemical

An nNOS/PSD-95 interaction inhibitor

More Information Supplier Page

ZL006 25 mg | ≥98%

Cayman Chemical

An nNOS/PSD-95 interaction inhibitor

More Information Supplier Page

ZL006 10 mg | ≥98%

Cayman Chemical

An nNOS/PSD-95 interaction inhibitor

More Information Supplier Page

ZL006 5 mg | ≥98%

Cayman Chemical

An nNOS/PSD-95 interaction inhibitor

More Information Supplier Page

ZL0420 25 mg | ≥98%

Cayman Chemical

A BRD4 inhibitor

More Information Supplier Page

ZL0420 10 mg | ≥98%

Cayman Chemical

A BRD4 inhibitor

More Information Supplier Page

ZL0420 5 mg | ≥98%

Cayman Chemical

A BRD4 inhibitor

More Information Supplier Page

ZLD1039 5 mg | ≥98%

Cayman Chemical

An inhibitor of EZH2

More Information Supplier Page

ZLD1039 1 mg | ≥98%

Cayman Chemical

An inhibitor of EZH2

More Information Supplier Page

ZLJ-6 25 mg | ≥98%

Cayman Chemical

Dual inhibitor of cyclooxygenase/5-lipoxygenase

More Information Supplier Page

ZLJ-6 10 mg | ≥98%

Cayman Chemical

Dual inhibitor of cyclooxygenase/5-lipoxygenase

More Information Supplier Page

ZLJ-6 5 mg | ≥98%

Cayman Chemical

Dual inhibitor of cyclooxygenase/5-lipoxygenase

More Information Supplier Page

ZLJ-6 1 mg | ≥98%

Cayman Chemical

Dual inhibitor of cyclooxygenase/5-lipoxygenase

More Information Supplier Page

ZLN005 50 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN005 25 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN005 10 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN005 5 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN005 (hydrochloride) 50 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN005 (hydrochloride) 25 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN005 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN005 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1α expression

More Information Supplier Page

ZLN024 50 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLN024 25 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLN024 10 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLN024 5 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLY032 50 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARδ agonist

More Information Supplier Page

ZLY032 25 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARδ agonist

More Information Supplier Page

ZLY032 10 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARδ agonist

More Information Supplier Page

ZLY032 5 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARδ agonist

More Information Supplier Page

ZLY28 1 mg | ≥90%

Cayman Chemical

An FXR agonist and inhibitor of FABP1

More Information Supplier Page

ZLY28 5 mg | ≥90%

Cayman Chemical

An FXR agonist and inhibitor of FABP1

More Information Supplier Page

ZM 241385 25 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 241385 10 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 241385 5 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 241385 1 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 306416 10 mg | ≥98%

Cayman Chemical

A VEGF receptor kinase inhibitor

More Information Supplier Page

ZM 306416 5 mg | ≥98%

Cayman Chemical

A VEGF receptor kinase inhibitor

More Information Supplier Page

ZM 306416 1 mg | ≥98%

Cayman Chemical

A VEGF receptor kinase inhibitor

More Information Supplier Page

ZM 323881 (hydrochloride) 25 mg | ≥98%

Cayman Chemical

A potent and selective VEGFR2 inhibitor

More Information Supplier Page

ZM 323881 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

A potent and selective VEGFR2 inhibitor

More Information Supplier Page

ZM 323881 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

A potent and selective VEGFR2 inhibitor

More Information Supplier Page